AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2013
Jan 9, 2013
29821_dirs_2013-01-09_e13a6cce-0f9b-441e-afac-5053620ec429.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-01-01
Reporting Person: Ballinger Kevin J. (SVP & Pres, Interven Cardio)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 91825.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Deferred Stock Units | $ | 2013-02-12 | Common Stock (5913.0000) | Direct | |
| Deferred Stock Units | $ | 2015-02-16 | Common Stock (34413.0000) | Direct | |
| Deferred Stock Units | $ | 2014-02-24 | Common Stock (6291.0000) | Direct | |
| Deferred Stock Units | $ | 2017-02-27 | Common Stock (15924.0000) | Direct | |
| Deferred Stock Units | $ | 2016-02-28 | Common Stock (22346.0000) | Direct | |
| Deferred Stock Units | $ | 2013-10-28 | Common Stock (2594.0000) | Direct | |
| Stock Option (Right to Buy) | $6.2800 | 2022-02-27 | Common Stock (37497.0000) | Direct | |
| Stock Option (Right to Buy) | $6.3100 | 2020-10-25 | Common Stock (100000.0000) | Direct | |
| Stock Option (Right to Buy) | $7.1600 | 2021-02-28 | Common Stock (62112.0000) | Direct | |
| Stock Option (Right to Buy) | $7.4100 | 2020-02-16 | Common Stock (23077.0000) | Direct | |
| Stock Option (Right to Buy) | $7.7100 | 2018-10-28 | Common Stock (36630.0000) | Direct | |
| Stock Option (Right to Buy) | $8.3000 | 2019-02-24 | Common Stock (35000.0000) | Direct | |
| Stock Option (Right to Buy) | $15.9100 | 2016-10-31 | Common Stock (17100.0000) | Direct | |
| Stock Option (Right to Buy) | $21.7800 | 2013-02-25 | Common Stock (8000.0000) | Direct |
Footnotes
F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 12, 2009, the first anniversary of the date of grant.
F3: This amount represents the unvested portion of DSUs awarded on February 12, 2008, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F4: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
F6: This amount represents the unvested portion of DSUs awarded on February 16, 2010, which will continue to vest in three equal annual installments on the anniversary of the date of grant.
F7: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
F8: This amount represents the unvested portion of DSUs awarded on February 24, 2009, which will continue to vest in two equal annual installments on the anniversary of the date of grant.
F9: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F10: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
F11: This amount represents the unvested portion of DSUs awarded on February 28, 2011, which will continue to vest in four equal annual installments on the anniversary of the date of grant.
F12: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 28, 2009, the first anniversary of the date of grant.
F13: This amount represents the unvested portion of DSUs awarded on October 28, 2008, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F14: Grant to the reporting person of an option to purchase 37,497 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F15: Grant to the reporting person of an option to purchase 100,000 shares of common stock vesting in four equal annual installments beginning on October 25, 2011, the first anniversary of the date of grant.
F16: Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
F17: Grant to the reporting person of an option to purchase 23,077 shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
F18: Grant to the reporting person of an option to purchase 36,630 shares of common stock on October 28, 2008. This option is fully vested.
F19: Grant to the reporting person of an option to purchase 35,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
F20: Grant to the reporting person of an option to purchase 17,100 shares of common stock on October 31, 2006. This option is fully vested.
F21: Grant to the reporting person of an option to purchase 8,000 shares of common stock on February 25, 2003. This option is fully vested.